UK markets close in 8 hours 18 minutes

Ginkgo Bioworks Holdings, Inc. (DNA)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
0.9246+0.0530 (+6.08%)
At close: 04:00PM EDT
0.9100 -0.01 (-1.58%)
After hours: 07:54PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
251,455
251,455
477,706
313,837
76,657
Cost of revenue
54,005
54,005
204,216
129,690
15,611
Gross profit
197,450
197,450
273,490
184,147
61,046
Operating expenses
Research development
580,621
580,621
1,052,643
1,149,662
159,767
Selling general and administrative
385,025
385,025
1,429,799
862,952
38,306
Total operating expenses
965,646
965,646
2,482,442
2,012,614
198,073
Operating income or loss
-768,196
-768,196
-2,208,952
-1,828,467
-137,027
Interest expense
93
93
106
2,373
2,385
Total other income/expenses net
-181,868
-181,868
67,397
-8,119
11,996
Income before tax
-892,940
-892,940
-2,121,399
-1,838,122
-124,834
Income tax expense
-71
-71
-15,027
-1,480
1,889
Income from continuing operations
-892,869
-892,869
-2,106,372
-1,836,642
-126,723
Net income
-892,869
-892,869
-2,104,929
-1,830,047
-126,609
Net income available to common shareholders
-892,869
-892,869
-2,108,072
-1,888,662
-126,609
Basic EPS
-0.41
-
-1.25
-1.35
-0.09
Diluted EPS
-0.41
-
-1.25
-1.39
-0.09
Basic average shares
1,914,120
-
1,679,061
1,359,849
1,485,061
Diluted average shares
1,914,898
-
1,679,839
1,360,373
1,485,061